ADAR1 Capital Management »

Scynexis shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Scynexis shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Scynexis

Tip: Access up to 7 years of quarterly data

All positions including Scynexis held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scynexis by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $201k 49k 4.07

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Scynexis

Dr. Jeffrey R. Jay, M.D.
Squadron Capital Management
Adage Capital Partners GP
Propel Bio Management
Woodline Partners
Vanguard Capital Management
Avidity Partners Management
Kingdon Capital Management
Millennium Management
Heights Capital Management
DAFNA Capital Management
Empery Asset Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies

View all funds holding Scynexis